Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystic fibrosis and insulin therapy: a reality check.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Multidrug-resistant (MDR) Gram-negative bacteria information leaflets.

The Journal of hospital infection·2016
Same author

Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party.

The Journal of hospital infection·2015
Same author

Implications of new European Union driving regulations on patients with Type 1 diabetes who participated in the Diabetes Control and Complications Trial.

Diabetic medicine : a journal of the British Diabetic Association·2012
Same author

Dual semantic encoding of homographs and homophones embedded in context.

Memory & cognition·2011
Same author

Diarrhea.

Canadian family physician Medecin de famille canadien·2011

Related Experiment Video

Updated: Jun 29, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Daptomycin in endocarditis and bacteraemia: a British perspective.

R E Warren1

  • 1Microbiology Laboratory, Royal Shrewsbury Hospital, Mytton Oak Road, Shrewsbury, Shropshire, UK. Rod.Warren@sath.nhs.uk

The Journal of Antimicrobial Chemotherapy
|October 10, 2008
PubMed
Summary

Daptomycin shows promise for treating Staphylococcus aureus infections and some enterococcal infections, especially vancomycin-resistant strains. Further research is needed to confirm its effectiveness and address potential resistance.

More Related Videos

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jun 29, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

In Vivo Mouse Model of Spinal Implant Infection
08:03

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Clinical Trials

Background:

  • Daptomycin is an antibiotic used for serious bacterial infections.
  • Its role in treating endocarditis and bacteremia requires comprehensive evaluation.

Purpose of the Study:

  • To assess the current clinical utility of daptomycin in treating endocarditis and bacteremia.
  • To integrate data from clinical trials, registries, case reports, animal models, and in vitro studies.

Main Methods:

  • Review of an open-label randomized comparative clinical trial.
  • Analysis of registry data and case reports.
  • Inclusion of relevant animal models and in vitro data.

Main Results:

  • Daptomycin demonstrates efficacy in Staphylococcus aureus bacteremia and endocarditis.
  • Evidence supports its use in vancomycin-resistant Enterococcus spp. infections.
  • Equivalence to comparator regimens and correlation of in vitro/in vivo findings are generally shown.

Conclusions:

  • Daptomycin is a viable option for specific bacterial infections, particularly Staphylococcus aureus and vancomycin-resistant Enterococcus.
  • Potential for resistance necessitates further investigation into higher doses or combination therapies (e.g., with rifampicin).
  • Gaps in clinical data, especially for streptococcal and enterococcal endocarditis, require additional trials; economic assessments are crucial for deployment decisions.